Home

Endotronix has announced the enrollment of the first two patients in the PROACTIVE-HF trial. The trial is a premarket investigational device exempt (IDE) study evaluating the safety and efficacy of the Cordella pulmonary artery pressure sensor system (Cordella sensor) for the treatment of heart failure. The first two patients were successfully implanted with the Cordella Sensor by Navin Kapur and Michael Kiernan (both Tufts Medical Center, Boston, USA) and Liviu Klein (University of California San Francisco, San Francisco, USA).

The prospective, multicentre, randomised, controlled, single-blind trial is expected to enrol more than 950 New York Heart Association (NYHA) Class III heart failure patients at up to 60 sites across the USA. The dual-arm trial design compares heart failure management using daily patient vital sign data versus daily vital sign plus pulmonary artery pressure data. Designed to show a definitive benefit for pulmonary artery pressure-guided management, the trial incorporates protocolised pulmonary artery pressure therapy guidelines and guideline-directed medical therapy for proactive heart failure management. Primary endpoints of the study include the reduction of heart failure hospitalisations and mortality. Additionally, the data from this trial will support US market access of the Cordella sensor and inform a national coverage decision from the Centers for Medicare & Medicaid Services (CMS). Endotronix also announced that last year they received Category B IDE Study approval from CMS, which will allow coverage of the Cordella sensor and routine care services during the trial.

Klein, national principal investigator of the PROACTIVE-HF trial, says: “Based on my early experience, the Cordella system offers an intuitive at-home patient experience, including a seated pulmonary artery pressure reading, for remote management. I am excited for the PROACTIVE-HF trial and look forward to clearly demonstrating the benefits of hemodynamic pulmonary artery pressure guided therapy and its impact on clinical outcomes.”

The Cordella sensor is not available for commercial use in any geography and is under clinical investigation in Europe (SIRONA II CE mark trial) and the USA (PROACTIVE-HF IDE Trial).

Source CardiovascularNews

Duc Tin CLinic

Chia sẽ qua facebook bài: First patients enrolled in PROACTIVE-HF trial of Cordella

Chia sẽ qua google bài: First patients enrolled in PROACTIVE-HF trial of Cordella

Chia sẽ qua twitter bài: First patients enrolled in PROACTIVE-HF trial of Cordella

Chia sẽ qua MySpace bài: First patients enrolled in PROACTIVE-HF trial of Cordella

Chia sẽ qua LinkedIn bài: First patients enrolled in PROACTIVE-HF trial of Cordella

Chia sẽ qua stumbleupon bài: First patients enrolled in PROACTIVE-HF trial of Cordella

Chia sẽ qua icio bài: First patients enrolled in PROACTIVE-HF trial of Cordella

Chia sẽ qua digg bài: First patients enrolled in PROACTIVE-HF trial of Cordella

Chia sẽ qua yahoo bài: First patients enrolled in PROACTIVE-HF trial of Cordella

Tin tức liên quan

Vesteck completes first-in-human use of several Suture-Tight devices

Age is just a number: Individual patient data meta-analysis probes safety of CEA in the elderly

Artificial intelligence can predict risk of complications after endovascular aneurysm repair

Bluegrass Vascular announces Journal of Vascular Surgery paper reporting use of Surfacer system

Vascular access creation: EndoAVF keeps future options open, but is not a replacement for surgical fistulas

SUPPORT CONSULTANT

Make an Appointment

I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

I sincerely thank you !. Tel: 0938303275

Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.